Brainstorm Cell Therapeutics, Inc. (BCLI)

1.123 -0.04 (-3.40%) USD  |  OTCM  |  Aug 28, 16:00
More

Brainstorm Cell Therapeutics Revenue Estimates for Next Fiscal Year

Revenue Estimates for Next Fiscal Year Chart

View Revenue Estimates for Next Fiscal Year for BCLI.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Revenue Estimates for Next Fiscal Year Chart
Start Trial

Historical Revenue Estimates for Next Fiscal Year Data

View and export this data back to 2023. Start Trial.
Date Value
August 17, 2026 --
February 21, 2026 --
December 08, 2025 --
August 15, 2025 --
August 14, 2025 --
July 23, 2025 --
July 07, 2025 --
May 27, 2025 --
May 19, 2025 --
April 09, 2025 --
April 04, 2025 --
January 06, 2025 --
December 12, 2024 --
Date Value
October 29, 2024 --
August 19, 2024 --
August 14, 2024 --
July 11, 2024 --
July 10, 2024 --
June 21, 2024 --
June 11, 2024 --
April 11, 2024 --
December 07, 2023 --
October 23, 2023 --
August 14, 2023 --
May 23, 2023 --
April 04, 2023 --

Revenue Estimates for Next Fiscal Year Range, Past 5 Years

View Revenue Estimates for Next Fiscal Year Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Revenue Estimates for Next Fiscal Year Benchmarks

View Revenue Estimates for Next Fiscal Year Benchmarks
Start Trial
NovelStem International Corp. Upgrade
Summit Therapeutics, Inc. Upgrade
Kezar Life Sciences, Inc. Upgrade
Protara Therapeutics, Inc. Upgrade
Clene, Inc. Upgrade

Revenue Estimates for Next Fiscal Year Related Metrics

EPS Estimates for Current Quarter Upgrade
EPS Estimates for Next Quarter Upgrade
EPS Estimates for Current Fiscal Year Upgrade
EPS Estimates for Next Fiscal Year Upgrade